| 0 (0%) | 12-26 19:29 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 13.74 | 1-year : | 14.41 |
| Resists | First : | 11.76 | Second : | 12.34 |
| Pivot price | 11.56 |
|||
| Supports | First : | 10.84 | Second : | 9.01 |
| MAs | MA(5) : | 11.46 |
MA(20) : | 11.53 |
| MA(100) : | 11.54 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 35.7 |
D(3) : | 39.7 |
| RSI | RSI(14): 47 |
|||
| 52-week | High : | 17.69 | Low : | 9.3 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AVNS ] has closed above bottom band by 31.6%. Bollinger Bands are 38.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.47 - 11.52 | 11.52 - 11.57 |
| Low: | 11.15 - 11.22 | 11.22 - 11.28 |
| Close: | 11.3 - 11.41 | 11.41 - 11.51 |
Wed, 24 Dec 2025
Why AVNS stock could be next leader - Price Support Zones & Low Cost Stock Ideas - Bollywood Helpline
Sun, 21 Dec 2025
How strong is AVNS stock earnings growth - Rate Hike & Target Return Focused Stock Picks - Улправда
Sun, 21 Dec 2025
93,572 Shares in Avanos Medical, Inc. $AVNS Bought by Squarepoint Ops LLC - MarketBeat
Thu, 18 Dec 2025
Liquidity Mapping Around (AVNS) Price Events - Stock Traders Daily
Wed, 19 Nov 2025
Insider Sale: SVP of $AVNS Sells 100 Shares | AVNS Stock News - Quiver Quantitative
Wed, 05 Nov 2025
Avanos Medical (AVNS) Net Losses Worsen 74.4% Annually, Undercutting Bullish Value Narratives - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 46 (M) |
| Shares Float | 43 (M) |
| Held by Insiders | 4 (%) |
| Held by Institutions | 99 (%) |
| Shares Short | 2,800 (K) |
| Shares Short P.Month | 2,380 (K) |
| EPS | -10.19 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.76 |
| Profit Margin | -67 % |
| Operating Margin | 0.2 % |
| Return on Assets (ttm) | 1.5 % |
| Return on Equity (ttm) | -46.7 % |
| Qtrly Rev. Growth | 4.3 % |
| Gross Profit (p.s.) | 7.88 |
| Sales Per Share | 15.07 |
| EBITDA (p.s.) | 1.6 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 104 (M) |
| Levered Free Cash Flow | 84 (M) |
| PE Ratio | -1.13 |
| PEG Ratio | 0 |
| Price to Book value | 0.68 |
| Price to Sales | 0.75 |
| Price to Cash Flow | 5.07 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |